Entera Bio entered a securities purchase agreement for a private placement led by funds affiliated with BVF Partners to issue and sell an aggregate of 7.83 million securities. The financing provides near-term capital for the clinical-stage biotech; deal economics (price, proceeds) were not disclosed in the report.
Entera Bio entered a securities purchase agreement for a private placement led by funds affiliated with BVF Partners to issue and sell an aggregate of 7.83 million securities. The financing provides near-term capital for the clinical-stage biotech; deal economics (price, proceeds) were not disclosed in the report.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.12
Ticker Sentiment
